qs102. tle3-a candidate biomarker of taxane response in breast cancer

286 ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS

GASTROINTESTINAL AND NUTRITION 4:FOREGUT

QS81. DEVELOPING A NATURAL ORIFICE TRANSLUMI-NAL ENDOSCOPIC SURGERY (NOTES®) ROUX-EN-Y GAS-TRIC BYPASS TECHNIQUE. A. K. Madan1, E. Lo Menzo1, J. M.Martinez1, C. Y. Ro1, A. Iglesias1, K. A. Khan2, D. S. Tichansky2;1University of Miami Miller School of Medicine, Miami, FL; 2Univer-sity of Tennessee Health Science Center, Memphis, TN

QS82. ANNUAL LINEAR PTH INCREASE MORE SIGNIFI-CANT IN WOMEN AFTER GASTRIC BYPASS. J. B. Bowen,K. L. Haines, S. F. Gallagher; University of South Florida College ofMedicine, Tampa, FL

QS83. SLEEVE GASTRECTOMY WITH VICRYL MESH IM-PROVES EXCESS WEIGHT LOSS. E. E. Frezza1, C. Witt2, C.Wei2, M. S. Wachtel2; 1University of Alabama at Birmingham, Bir-mingham, AL; 2Texas Tech University Health Sciences Center, Lub-bock, TX

QS84. PERIOPERATIVE DIFFERENCES BETWEEN THELAP-BAND® AND REALIZE™ BANDS: INITIAL EXPERI-ENCE. P. H. Nguyen, D. Stefanidis, T. S. Kuwada, A. S. Prabhu,Y. Y. Yurko, A. E. Lincourt, B. Heniford, K. S. Gersin; CarolinasMedical Center, Charlotte, NC

QS85. RECENT TRENDS IN BARIATRIC SURGERY CASEVOLUME. G. P. Kohn, J. A. Galanko, D. W. Overby, T. M. Farrell;University of North Carolina, Chapel Hill, NC

QS86. THE ROLE OF THE STOMACH IN RESTRICTIVE PRO-CEDURES FOR MORBID OBESITY. E. E. Frezza1, S. E.Wozniak2, L. Gee2, A. Moreland2, M. S. Wachtel2; 1University ofAlabama at Birmingham, Birmingham, AL; 2Texas Tech UniversityHealth Sciences Center, Lubbock, AL

QS87. THE INCIDENCE OF VITAMIN A DEFICIENCY ANDOCULAR SYMPTOMS AFTER ROUX-EN Y GASTRIC BY-PASS. M. J. Eckert, J. T. Perry, V. Y. Sohn, D. S. Cuadrado, J. H.Boden, M. J. Martin, R. M. Rush, S. R. Steele; Madigan ArmyMedical Center, Tacoma, WA

QS88. INDICATOR OF CERVICAL LYMPH NODE METASTA-SIS IN THORATIC ESOPHAGEAL SQUAMOUS CELL CARCI-NOMA: CONSECUTIVE 100 PATIENTS. Y. Imamura, N. Ha-yashi, N. Satoh, R. Karashima, Y. Hiyoshi, Y. Nagai, N. Yoshida, E.Toyama, M. Watanabe, H. Badeo; Kumamoto University, Kumamotocity, Japan

QS89. --------------WITHDRAWN-------------

QS90. CALCIUM-SENSING RECEPTOR: A POTENTIAL OFF-SWITCH FOR GASTRIC ACID SECRETION. E. Arena1, U. Hell-mich2, A. Schilcher2, J. P. Geibel1; 1Yale University, New Haven, CT;2Paracelsus University, Salzburg, Austria

QS91. LAPAROSCOPIC ANTRECTOMY FOR THE TREAT-MENT OF TYPE I GASTRIC CARCINOID TUMORS. J. Ozao-Choy, K. Buch, J. A. Strauchen, R. P. Warner, C. M. Divino; MountSinai School of Medicine, New York, NY

QS92. IMPACT OF VASCULAR ANASTOMOSIS TO THE GAS-

THE MANAGEMENT OF THORACIC ESOPHAGEAL CAN-CER. T. Nakamura, T. Imanishi, S. Tahara, D. Kuroda, Y. Kuroda;Kobe University, Graduate School of Medicine, Kobe, Japan

QS93. MODULATION OF HEAT SHOCK PROTEIN EXPRES-SION IN HUMAN GASTRIC EPITHELIUM: EFFECT OF OX-YGEN FREE RADICAL INDUCED APOPTOSIS. A. M. Leung,M. J. Redlak, T. A. Miller; Virginia Commonwealth University, Med-ical College of Virginia, Richmond, VA

QS94. A PROPENSITY-SCORE ANALYSIS OF COLONIC ANDGASTRIC CONDUIT FOR ESOPHAGEAL RECONSTRUC-TION FOLLOWING ESOPHAGOGASTRECTOMY FOR CAN-CER. K. T. Sawicki, J. S. Lee, L. K. Perigo, M. B. Orringer, A. C.Chang; University of Michigan, Ann Arbor, MI

QS95. RANDOMIZED TRIALS EVALUATING THE PHYSIO-LOGIC IMPACT OF NOTES. J. Bingener, E. Moran, C. Gostout;Mayo Clinic Rochester, Rochester, MN

QS96. LAPAROSCOPIC RESECTION OF GASTROINTESTI-NAL STROMAL TUMORS (GIST). T. Anene-Maidoh, K. A.Chojnacki, B. Profeta, F. E. Rosato, Jr., E. L. Rosato, A. C. Berger;Thomas Jefferson University, Philadelphia, PA

QS97. DOES CIRCULAR STAPLED ESOPHAGOGASTRICANASTOMOTIC SIZE OR LEAK AFFECT THE INCIDENCEOF POST OPERATIVE STRICTURES? L. A. Gutierrez1, S. S.Yendamuri2, T. L. Demmy2, H. R. Nava2, T. Mashtare1, N. I. Khush-alani2, G. Y. Yang2, C. E. Nwogu2; 1SUNY Buffalo, Buffalo, NY;2Roswell Park Cancer Institute, Buffalo, NY

QS98. THE IMPORTANCE OF INTEGRATED MULTI-MODALITY THERAPIES IN THE TREATMENT OF GASTRICADENOCARCINOMA. M. C. Cheung, D. Franceschi, M. Scarlata,L. G. Koniaris; University of Miami, Miami, FL

QS99. ANASTOMOTIC COMPLICATIONS ASSOCIATEDWITH STAPLED VERSUS HAND-SEWN CERVICALESOPHAGO-GASTRIC ANASTOMOSIS. S. G. Worrell, S. K. Mit-tal, S. Mumtaz, T. Kazuto; Creighton University, Omaha, NE

QS100. DOES ABDOMINAL WALL CLOSURE WITH PRO-PHYLACTIC BIOPROSTHETIC MATERIAL PROTECTAGAINST THE DEVELOPMENT OF INCISIONAL HERNIA INHIGH RISK PATIENTS? O. H. Llaguna, D. V. Avgerinos, P.Nagda, D. Elfant, E. C. Goodman, I. Leitman; Albert Einstein Col-lege of Medicine-Beth Israel Medical Center, New York, NY

ONCOLOGY 9: BREAST-CLINICAL

QS101. RISING RATES OF CONTRALATERAL PROPHYLAC-TIC MASTECTOMY AMONG PATIENTS WITH DUCTAL CAR-CINOMA IN SITU. T. Tuttle, S. Jarosek, E. Habermann, A. Ar-rington, A. Abraham, T. Morris, B. Virnig; University of Minnesota,Minneapolis, MN

QS102. TLE3-A CANDIDATE BIOMARKER OF TAXANE RE-SPONSE IN BREAST CANCER. S. A. Kulkarni1, D. G. Hicks2, N.Watroba1, C. Murekesyisoni1, R. Beck3, B. Z. Ring3, N. Estopinal4,M. T. Schreeder4, R. S. Seitz3, D. Ross3; 1Roswell Park CancerInstitute/SUNY Buffalo, Buffalo, NY; 2University of Rochester,Rochester, NY; 3Applied Genomics, Inc., Burlingame, CA; 4Clearview